Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Hair loss in twins may be linked to family history of hair loss, high blood pressure, heart disease, and possibly anxiety, but more research is needed.

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Non-immune factors play a significant role in alopecia areata.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Minoxidil and finasteride treat hair loss; more research needed for other options.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Alternative treatments show promise for hair growth beyond traditional methods.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.